Madeline Lane
Family · Kansas City, KSNPI 1124418843
Payments from drug & device makers
Across 91 payments — averaging $22.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$456
- E.r. Squibb & Sons, L.L.C.$367
- Lilly USA, LLC$226
- Novartis$220
- Dermavant Sciences, Inc.$160
- AbbVie$145
- plus $490 from 16 others
What the payments were for
- Food & beverage$1,97596%
- Education$904%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 18 | $456 |
| E.r. Squibb & Sons, L.L.C. | 10 | $367 |
| Lilly USA, LLC | 13 | $226 |
| Novartis | 9 | $220 |
| Dermavant Sciences, Inc. | 7 | $160 |
| AbbVie | 7 | $145 |
| UCB, Inc. | 5 | $107 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $54 |
| Convatec Inc. | 1 | $50 |
| Boehringer Ingelheim | 2 | $40 |
| GSK | 2 | $28 |
| Almirall LLC | 1 | $25 |
| Genentech USA, Inc. | 3 | $24 |
| Fresenius Kabi USA, LLC | 1 | $23 |
| Pfizer | 1 | $22 |
| LEO Pharma Inc. | 1 | $21 |
| Sun Pharmaceutical Industries Inc. | 1 | $20 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Novo Nordisk | 1 | $18 |
| Boston Scientific | 1 | $15 |
| Organon | 1 | $14 |
| Endogastric Solutions, Inc | 2 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sotyktu$229
How this compares
$2,065 in reported general payments places this provider in the 85th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 17 | $1,440 |
| Ketoconazole | 58 | $817 |
| Doxycycline Hyclate | 26 | $762 |
| Clobetasol Propionate | 22 | $640 |
| Metronidazole | 23 | $597 |
| Tacrolimus | 12 | $515 |
| Desonide | 19 | $499 |
| Imiquimod | 23 | $488 |
| Triamcinolone Acetonide | 45 | $300 |
| Mupirocin | 42 | $252 |
| Terbinafine Hcl | 13 | $59 |
Paid to pharmacies, not to this prescriber.
Other family in Kansas City
- Zohra HussainiKansas City$329K
- Adam CaseKansas City$34K
- Kristina DelaneyKansas City$27K
- Amanda WilliamsKansas City$20K
- Mindy EldridgeKansas City$12K
- Liza RodriguezKansas City$11K
- Jhunne GalimbaKansas City$6K
- Graceann SandriKansas City$6K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.